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Abstract
Aim: the purpose of the actual study was to evaluate, in the third trimester of pregnancy, the 
relationship between the formation of anti-inflammatory IL-10 cytokine and several indicators 
of moderate and severe preeclampsia. Materials and methods: in the third trimester of gesta-
tion, examination of the biochemical markers of preeclampsia (PE) and maternal IL-10 levels 
was conducted in 100 women with pregnancies complicated by varying degrees of preeclamp-
sia and in 100 normotensive patients, hospitalized at the University Clinic of Gynecology and 
Obstetrics, Skopje, Republic of Macedonia. Patients with preeclampsia were categorized into 
moderate and severe preeclampsia groups according to the degree of preeclampsia. Logistic 
regression of the different parameters for the occurrence of severe preeclampsia analysis was 
used to determine the predictive value. Results: the regression analysis detected systolic blood 
pressure of 160 mmHg or higher, diastolic blood pressure of 100 mmHg or higher, persistent 
proteinuria in pregnancy, serum LDH concentration of 450 U/L or higher, and reduced serum 
concentrations of IL-10 as significant predictors of severe preeclampsia. Conclusion: signifi-
cantly, lower IL-10 concentrations in maternal serum in patients with severe preeclampsia in 
comparison with respective concentrations in patients with moderate preeclampsia can be 
considered as major pathognomonic laboratory sign of severe form of preeclampsia.
Keywords: cytokines, indicators, preeclampsia, biochemical markers, prediction
1. Introduction
Preeclampsia (PE), one of the current problems of obstetrics, is a pathological multifacto-
rial syndrome that occurs in the second half of pregnancy and is manifested through a basic 
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
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triad of symptoms: swelling, proteinuria, and hypertension and in severe cases, convulsions 
and coma [1, 2]. Preeclampsia remains one of the most sophisticated problems of modern 
obstetrics and gynecology. It generally determines the structure of maternal and perinatal 
morbidity and mortality. The role of immune mechanisms contributing to the development of 
a normal pregnancy is widely discussed. Their involvement in the pathogenesis of pregnancy 
complications such as preeclampsia was also noted [3]. The analysis of the scientific literature 
reveals the conclusion that many aspects of the pathogenesis of preeclampsia are related with 
systemic inflammatory response syndrome with the development of a destructive inflam-
matory process, immune disorders, and the imbalance of cytokine regulation of gestation 
processes [4–6].
The role of vascular endothelial damage with the development of generalized arteriolar 
spasm as one of the leading mechanisms in the pathogenesis of preeclampsia is supposed to 
be significant. However, the relationship between the development of endothelial dysfunc-
tion and disruption of cytokine regulation in different clinical forms of preeclampsia also 
requires further research and is currently represented in several scientific works [7].
Proteinuria has been proposed and studied as both an indicator of the severity of the disease 
and a predictor of the outcome in preeclampsia. Many clinicians still make major manage-
ment decisions based on the degree of proteinuria in these patients.
Cytokines, such as IL-2, IL-8, and TNF-α, are pro-inflammatory, increased in the blood, in 
leukocytes during PE. Elevated concentrations of TNF-α have been observed in the blood 
of women with PE [8]. Further studies support the idea of the involvement of the maternal 
immune system in the development of preeclampsia which comes from the prim paternity 
theory [9]. This hypothesis holds that the risk of developing preeclampsia is highest in the 
first pregnancy [10], and a previous normal pregnancy is associated with a lowered incidence 
of preeclampsia [11] in the subsequent pregnancy.
In contrast to normal pregnancy, there are indications of increased inflammatory responses 
[12] and also of an immune deviation toward Th1 in the established preeclampsia preg-
nancy [13]. Roberts et al. [14] were one of the first to suggest that mediators released in 
preeclampsia are responsible for the endothelial damage seen in preeclampsia. Subsequent 
to the damage, the injured endothelium initiates a dysfunctional cascade of coagulation, 
vasoconstriction, and intravascular fluid redistribution that results in the clinical syndrome 
of preeclampsia [15].
Numerous studies show that the balance of cytokines has special importance in the regulation 
of pregnancy. However, the diagnostic and prognostic significance of breaches in the immune 
balance during preeclampsia has not yet been determined.
2. Aim
The purpose of the actual study was to evaluate the relationship between the formation of 
anti-inflammatory cytokines and several indicators of moderate and severe preeclampsia in 
the third trimester of pregnancy.
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3. Materials and methods
We conducted a prospective study of 50 women with pregnancies complicated by vary-
ing degrees of preeclampsia in the third trimester of gestation with singleton pregnancies 
between 28 and 40 weeks’ gestation (±1 week), parity (parity 1 l–4 and parity > 4), and mater-
nal age (<20 years, 20–35, and >35 years) and in 50 normotensive patients without threatening 
signs of hypertension and preeclampsia, hospitalized at the University Clinic of Gynecology 
and Obstetrics, Skopje, Republic of Macedonia.
The severity of preeclampsia was determined according to the definition of the WHO Handbook 
for Guideline Development, Geneva, 2010. Our inclusion criteria were reproductive age, diag-
nosed moderate and severe preeclampsia based on the criteria for classification at the time of 
collection of maternal serum, and the patients’ informed consent for inclusion in the survey.
Exclusion criteria were acute and chronic genital and extra genital diseases (essential hyper-
tension, heart failure, diabetes, morbid obesity, immunodeficiency, systemic diseases, chronic 
infectious diseases, genetic pathology).
Patients with preeclampsia were categorized into moderate (m PE) group A and severe (S PE) 
preeclampsia group B according to the degree of preeclampsia.
Cytokine levels in the serum were measured by the “sandwich” method of solid-phase 
enzyme immunoassay using double antibody. As a standard for comparison of each reaction, 
recombinant cytokines were used, which are part of the test—whale.
Statistical data processing was done using the SPSS 13.0 software for Windows.
4. Results
Regarding patients’ distribution by ethnicity, in Table 1, Albanians represented more than half of 
the women with preeclampsia as 44% of participants with symptoms of medium and 68% with 
symptoms of severe PE. Pregnant Albanians (68%) dominate in the group with normal tension.
The average body mass index (BMI) in the group of pregnant women with preeclampsia was 
34.33 ± 4.5—that was not significantly higher than tile average body mass of the control group 
(32.88 ± 3.8) (p = 0.09). The difference between the average BMI of pregnant women with 
moderate and severe PE and normotensive patients was significant (F = 3.8, p = 0.026). Namely, 
pregnant women with severe PE had significant higher average BMI than normotensive preg-
nant women (35.57 ± 4.11 vs. 32.88 ± 3.8, p = 0.025).
Statistical analysis is showed, not significant differences in the levels of interleukin 10 in 
serum between pregnant women with preeclampsia and healthy pregnant women (p = 0.5), 
but the difference between moderate preeclampsia, severe preeclampsia, and control group 
was highly significant (p < 0.01) due to the lower levels of this interleukin in the severe pre-
eclampsia group comparing moderate preeclampsia in relation to the control and due to the 
significant lower values when comparing control in relation to the moderate preeclampsia 
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group. Average concentrations of lL-10 in serum were 23.2 ± 40.7 pg/ml in the total group 
of preeclampsia patients, 45.5 ± 48.4 pg/ml in the group with moderate preeclampsia, and 
0.8 ± 0.4 pg/ml in the group with severe preeclampsia. In patients with normal tension, the 
average serum concentration of interleukin 10 was 4.2 ± 6.7 pg/ml.
Study data demonstrated that in pregnant women with pregnancy complicated by preeclamp-
sia, the serum concentration of anti-inflammatory interleukin 10 is confirmed as a significant 
predictor of the occurrence of severe preeclampsia (Table 2). Increased serum concentrations 
of interleukin 10 (in pg/ml) reduced the likelihood of the development of severe preeclampsia 
by 89.6% (95% CI 0.016–0.678).
Figures 1–3 show that the results of bivariate analysis are of the relationships between serum 
maternal concentration of IL-10 and serum enzyme LDH, creatinine, platelets, proteinuria, 
and uric acid.
The obtained values of Pearson’s coefficients indicate negative correlations of interleukin 10 with 
LOH and proteinuria, whereas the correlations of lL-10 with creatinine platelets and uric acid 
were positive. However significant correlations were confined between interleukin 10 and plate-
lets as well as between IL-10 and proteinuria. The correlation with the platelet count was positive 
which means that significantly higher concentration of interleukin 10 was confirmed in patients 
with higher number of platelets in the blood and vice versa. The correlation between interleukin 
Variable Groups
All PE
N = 50
Moderate PE
N = 25
Severe PE
N = 25
Control (C)
N = 50
Age (years)
mean ± SD
32.06 ± 4.8 29.9 ± 4.7 34.2 ± 3.85 31.8 ± 4.8
All PE/C t = 0.27 p = 0.8
mPE/sPE/C; F = 5.5; p = 0.005 post hoc mPE/sPE p = 0.004
Gestational week, mean ± SD 34.99 ± 3.5 35.5 ± 3.4 34.4 ± 3.6 34.8 ± 3.6
All PE/C; t = 0.2; p = 0.8
mPE/sPE/C F = 0.6 p = 0.5
Ethnicity n %
Macedonian 18 (36%) 10 (40%) 8 (32%) 15 (30%)
Albanian 28 (56%) 11 (44%) 17 (68%) 34 (68%)
Romani 4 (8%) 4 (16%) 0 1 (2%)
BMI mean ± SD, range 34.33 ± 4.5
24.2–44
33.1 ± 4.7
24.2–41
35.57 ± 4.1
27–44
32.88 ± 3.8
27–43.9
All PE/C; t = 1.7; p = 0.09
Table 1. Age, gestational week, BMI, and IL-10 serum concentration in women with moderate and severe preeclampsia, 
and women with normal blood pressure (control group).
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Variable B S.E. Wald Sig. Exp(B) 95.0% CI for Exp(B)
Age 0.2 0.086 5.350 0.021 1.221 1.031 1.446
Nulliparity (present) 1.816 1.114 2.657 0.103 6.145 0.692 54.534
Systolic blood pressure 
(≥160 mmHg)
3.711 1.053 12.412 0.000 40.900 5.189 322.371
Diastolic blood pressure 
(≥100 mmHg)
2.414 0.843 8.192 0.004 11.176 2.140 58.360
Proteinuria (present) 3.081 1.307 5.56 0.018 21.785 1.682 282.123
LDH ≥ 450 (U/L) 2.066 0.915 5.102 0.024 7.896 1.314 47.433
Albumin (serum) (g/L) −0.239 0.125 3.66 0.056 0.787 0.616 1.006
Creatinine (serum) (umol/L) −0.067 0.035 3.696 0.055 0.935 0.873 1.001
Platelets
(≤150)
−0.006 0.013 0.236 0.627 0.994 0.97 1.019
IL-10 (pg/ml) −2.324 1.051 4.888 0.027 0.098 0.012 0.768
Dependent variable: severe preeclampsia.
Table 2. Multivariate logistic regression analysis for the factors predictors of severe preeclampsia.
Figure 1. Correlation IL-10/LDH: r = −0.215 and p = 0.134.
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Figure 3. Correlation IL-10/platelets.
Figure 2. Correlation IL-10/creatinine: r = 0.134 and p = 0.355.
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10 and proteinuria was negative showing that the serum concentration of interleukin 10 was 
significantly lower in patients with higher amount of proteins in the urine and vice versa.
5. Discussion
This study demonstrates differences in IL-10 levels in women with preeclampsia compared to 
the levels in women with a normal pregnancy outcome.
We found that in pregnant women with preeclampsia the increased serum concentrations of 
IL-10 predicted lower likelihood for the development of severe preeclampsia.
Longitudinal studies in mice demonstrate a sequential change in the cytokine profile in serum 
including interleukin 10 in peripheral blood and release from spleen elements as pregnancy 
advances.
In the second half of pregnancy, IL-10 inhibition in mice is related with fetal growth retardation 
[16]. Progesterone has been shown to increase Th2-type responses in T cells [17]. This study dem-
onstrated that there is a significant alteration in the serum concentration of lL-10 in severe pre-
eclampsia compared with normal pregnancy and in moderate preeclampsia groups of patients.
The regression analysis applied in this study showed diastolic blood pressure of 100 mmHg 
or higher, systolic blood pressure of 160 mmHg or higher, persistent proteinuria in preg-
nancy, the serum LDH concentration of 450 U/L or higher, and reduced serum concentra-
tions of IL-10 in maternal serum as significant predictors of severe preeclampsia. While other 
variables predicted the development of severe preeclampsia, IL-10 decreased such likelihood. 
IL-10 was also found to be negatively correlated with proteinuria and positively correlated 
with blood platelets. Significantly higher concentration of IL-10 was confirmed in patients 
with higher number of platelets in the blood. The serum concentration of IL-10 was signifi-
cantly lower in patients with higher amount of proteins in the urine.
This study demonstrated platelet count and proteinuria as significant predictors of serum 
IL-10 concentration—urine proteins predicting lower serum IL-10 while platelets count pre-
dicting higher serum concentration of interleukin 10.
Other studies suggest a proportional link between the level of proteinuria and adverse 
clinical outcomes. In recent study 13,000 pregnant women found significant proteinuria, 
defined as 21 or more on dipstick analysis, and it was associated with an increase in pre-
maturity rates, intrauterine fetal growth restriction, and increased neonatal morbidity and 
mortality when associated with hypertension [18]. Other studies suggest that it is the presence 
of proteinuria rather than the severity, which is associated with poorer outcomes in these com-
plications for mother and stillbirth. There is evidence that even the finding of trace proteinuria 
in pregnant women with hypertension is associated with an increase in adverse outcomes.
Taking into consideration changes of anti-inflammatory cytokine concentrations in severe 
preeclampsia, the moderate phase can be analyzed as a critical stage in complicated 
pregnancy.
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6. Conclusion
Cytokines play critical, essential roles in signaling between cells of the immune system, with 
a prolific range of regulatory activities including the stimulation, recruitment, activation, 
destroying, and suppression of immune and nonimmune cells.
Analyzing cytokines at the end of pregnancy, last trimester complicated with preeclampsia, 
is useful. The moderate phase can be considered a critical stage in preeclampsia that comes to 
the most functional strain homeostatic system.
Abbreviation
BMI body mass index
PE preeclampsia
TNF-α tumor necrosis factor-α
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